Metraipolis › archive › dc_12fb1bc66e17

Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy — Europe PMC PMID:41652244

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41652244
DOI
10.1007/s00467-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-06T01:47:26.800Z
SHA-256 of the archived text
df39f93697b4665d08f9b8a415dcb6bc346938a1b69a1540a5010023b4e482ae
Stable URL of this page
https://metraipolis.com/documento/dc_12fb1bc66e17

How to cite

Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy — Europe PMC PMID:41652244 — Europe PMC (en), https://europepmc.org/article/MED/41652244 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_12fb1bc66e17 (Metraipolis archive dc_12fb1bc66e17, sha256 df39f93697b4665d08f9b8a415dcb6bc346938a1b69a1540a5010023b4e482ae)
BibTeX
@misc{dc12fb1bc66e17,
  title = {Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy — Europe PMC PMID:41652244},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41652244},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_12fb1bc66e17; sha256 df39f93697b4665d08f9b8a415dcb6bc346938a1b69a1540a5010023b4e482ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41652244. Agents can read the archived copy with the MCP tool read_document.